Recurrent Vulvovaginal Candidosis

Hurley R. Inveterate vaginal thrush. Practitioner 1975; 215: 753–6

Kaufman RH Friedrich EG Gardner HL . Benign diseases of the vulva and vagina. Year Book Medical, 1989

Carroll CJ Hurley R Stanley VC . Criteria for the diagnosis of Candida vulvovaginitis in pregnant women. J Obstet Gyaecol Br Comm 1973; 80: 258–63

Drake TE Maibach HI . Candida and candidiasis. Cultural conditions, epidemiology and pathogenesis. Postgrad Med J 1973; 53: 83–7

Hesseltine HC Borts IC Plass ED . Pathogenicity of the monilia (Castellani) vaginitis and oral thrush. Am J Obstet Gynecol 1934; 27: 112–16

Odds FC . Candida and candidosis, 2nd edn. London: Baillière Tindall, 1988: ch 7, 8 and 11

Odds FC Webster CE Fisk PG Riley Mayaranathan P Simmons P. Candida species and C albicans biotypes in women attending clinics in genitourinary medicine. J Med Microbiol 1989; 29: 51–4

Hunter PR Fraser C. Use of modified resistogram to type Candida albicans isolated from cases of vaginitis and from faeces in the same geographical area. J Clin Pathol 1987; 40: 1159–61

Odds FC Abbott AB . A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species. Sabouraudia 1980; 18: 301–17

Warnock DW Speller DCE Day JK Farrell AJ . Resistogram method of for differentiation of strains of Candida albicans . J Appl Bacteriol 1979; 46: 571–8

Cassone A De Bernadis F Mondello F Ceddia T Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987; 156: 777–83

Davidson F. Yeasts and circumcision in the male. Br J Vener Dis 1977; 53: 121–3

Thin RN Leighton M Dixon MJ . How often is genital yeast infection sexually transmitted? BMJ 1977; 2: 93–4

Foxman B. The epidemiology of Vulvovaginal candidiasis: Risk factors. Am J Public Health 1990; 80: 329–31

Horowitz BJ Edelstein SW Lipman L. Sexual transmission of Candida. Obstet Gynecol 1987; 69: 883–6

Hilton AL Warnock DW . Vaginal candidiasis and the role of the digestive tract as a source of infection. Br J Obstet Gynaecol 1975; 82: 922–6

Bertholf ME Stafford MJ . Colonisation of Candida albicans in vagina, rectum and mouth. J Fam Pract 1983; 16: 919–24

O'Connor MI Sobel JD . Epidemiology of recurrent vulvovaginal candidiasis. J Infect Dis 1986; 154: 358–63

Sobel JD . Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547–57

Soll DR Galask R Isley S . Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol 1989; 27: 681–90

Hopwood V Crowley T Horrocks CT Milne JD Taylor P Warnock DW . Vaginal candidosis: Relation between yeast counts and symptoms and clinical signs in non pregnant women. Genitourin Med 1988; 64: 331–4

Odds FC Webster CE Mayaranathan P Simmons PD . Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol 1988; 26: 277–83

Vellupillai S Thin RN . Treatment of vulvovaginal infection with nystatin. Practitioner 1977; 219: 897–901

Milne JD Warnock DW . Effect of simultaneous oral and vaginal treatment on the rate of cure of and relapse in vaginal candidosis. Br J Vener Dis 1979; 55: 362–5

Nystatin Multicentre Study Group. Therapy of candidal vaginitis: The effect of eliminating intestinal Candida. Am J Obstet Gynecol 1986; 155: 651–5

Bisschop MPJM Merkus JMWM Scheyground H Van Cutsem J. Co-treatment of the male partner in vaginal candidosis: A double blind randomised control study. Br J Obstet Gynaecol 1986:93:79–81

Calderon-Marquez JJ . Itraconazole in the treatment of vaginal candidosis and the effect of treatment of the sexual partner. Rev Infect Dis 1987; 9: S143–5

Sobel JD . Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985; 3: 435–40

International Multicentre Trial. Comparison of single dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidosis. Br J Obstet Gynaecol 1989; 96: 226–32

Sobel JD . A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986; 315: 1455–8

Rhoads AL Wright C Redfield R Burke DS . Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987; 257: 3105–7

Hobbs JR Brigden Davidson F Kahan Oates JK . Immunological aspects of Candidal vaginitis. Proc R Soc Med 1977; 70 (suppl 4): 11–13

Syverson RE Buckley H Gibian J . Cellular and humoral immune status in women with chronic Candida vaginitis . Am J Obstet Gynecol 1979; 134: 624–7

Mendling W Koldovsky U. Immunological findings in patients with chronically recurrent vaginal candidosis and new therapeutic approaches. Mycoses 1989; 32: 386–90

Witkin SS Hirsh J Ledger WJ . A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 1986; 155: 790–5

Kalo-Kein A Witkin SS . Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am J Obstet Gynecol 1989; 161: 1132–6

Cuff CF Taub D Rodgers TJ . The induction of T-suppressor cells with a soluble extract of Candida albicans . Cell Immunol 1989; 122: 71–82

Romero-Piffiguer MD Vucovich PR Riera CM . Secretory IgA and secretory component in women affected by recidivant vaginal candidiasis. Mycopathologia 1985; 91: 165–70

Ratnam KV Lee CT Wong TW . The significance of Candida specific serum IgE in recurrent vaginal candidiasis. Ann Acad Med Singapore 1987; 16: 306–9

Witkin SS Jeremias J Ledger WJ . Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol 1989; 27: 57–8

Davidson F Oates JK . The pill does not cause “thrush”. Br J Obstet Gynaecol 1985; 92: 1265–6

Dennerstein GJ . Depo-provera in the treatment of recurrent vulvo-vaginal candidiasis. J Reprod Med 1986; 31: 801–3

Wira CR Sandoe CP . Effect of uterine imunization and oestradiol on specific IgA and IgG antibodies in uterine, vaginal and salivary secretions. Immunology 1989; 68: 24–30

Segal E Soroka A Schechter A. Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and candidal vaginitis. Sabouraudia: J Med Vet Mycol 1984; 22: 191–200

Masfari AN Duerden BI Kinghorn GR . Quantitative studies of vaginal bacteria. Genitourin Med 1986; 62: 256–63

Sobel JD Myers PG Kaye D Levison ME . Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis 1981; 143: 76–83

Horowitz BJ Edelstein SW Lippman L. Sugar chromatography studies in recurrent Candida vulvovaginitis. J Reprod Med 1984; 29: 441–3

Reed BA Slattery ML French TK . The association between dietary intake and reported history of Candida vulvovaginitis. J Fam Pract 1989; 29: 509–15

Edman J Sobel JD Taylor ML . Zinc status in women with recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1986; 155: 1083–5

Davidson F Hayes J Hussein S. Recurrent genital candidosis and iron metabolism. Br J Vener Dis 1977; 53: 123–5

Elegbe IA Elegbe I. Quantitiative relationships of Candida albicans infections and dressing patterns in Nigerian women. Am J Public Health 1983; 73: 450–2

Sobel JD . Vulvovaginal candidiasis—what we do and do not know. Ann Intern Med 1984; 101: 390–2

Fleury FJ . Adult vaginitis. Clin Obstet Gynecol 1981; 24: 2–5

Bisschop MPMJ Merkus JMWM van Cutsem Nuyten STM . Yoghurt oraal of vaginaaal? De werkzaamheid van yoghurt bij de behandeling van candidosis vaginalis? Ned Tijdschr Geneeskd 1987; 131: 159–61

Balsdon MJ Tobin JM . Recurrent vaginal candidosis: Prospective study of maintenance miconazole treatment. Genitourin Med 1988; 64: 124–7

Son Roth AC Milsom Forssman L Wahlen P. Intermittent prophylactic treatment of recurrent vaginal candidiasis by post menstrual application of a clotrimazole 500 mg vaginal tablet. Genitourin Med 1990; 66: 357–60

Bushell TEC Evans EGV Meaden JD Milne JD Warnock DW . Intermittent local prophylaxis against recurrent vaginal candidosis. Geniturin Med 1988; 64: 335–8

Sobel JD Schmitt PA Meriwether C. Clotrimazole treatment of recurrent and chronic Candida vulvovaginitis. Obstet Gynecol 1989; 73: 330–4

Houang E. Fluconazole in recurrent vaginal candidiasis: Preliminary results of a double blind, randomized clinical trial. In: Richardson RG , ed. Fluconazole and its role in vaginal candidiasis. London: Royal Society of Medicine (International congress and symposium series) 1989:33–5

Levy DA Bohbot JM Catalan F Normier G Pinel AM d'Hinterland L. Dussourd Phase II study of D.651, and oral vaccine designed to prevent recurrences of vulvovaginal candidiasis. Vaccine 1989:7:339–40

Rigg D Miller MM Metzger J. Recurrent allergic vulvovaginitis. Treatment with Candida albicans allergen immunotherapy. Am J Obstet Gynecol 1990; 162: 332–6